CELGZ Trademark

Trademark Overview


On Thursday, October 7, 2010, a trademark application was filed for CELGZ with the United States Patent and Trademark Office. The USPTO has given the CELGZ trademark a serial number of 85147093. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 31, 2021. This trademark is owned by Celgene Corporation. The CELGZ trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

[ Pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of oncology, inflammation, dermatology and ophthalmology diseases and illnesses ]

Research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely, pharmacogenetic tests, personalized medical tests, gene sequencing-based tests and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; providing pharmaceutical information services in all media; scientific research services; design for others in the field of DNA-based assays, DNA sequencing protocols, immunoassay and methods for drug discovery; scientific research, namely, development of pharmaceuticals and development of diagnostic methods in the field of clinical laboratory testing; agrochemical product development for others
celgz

General Information


Serial Number85147093
Word MarkCELGZ
Filing DateThursday, October 7, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 31, 2021
Registration Number3984641
Registration DateTuesday, June 28, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2011

Trademark Statements


Goods and Services[ Pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of oncology, inflammation, dermatology and ophthalmology diseases and illnesses ]
Goods and ServicesResearch in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely, pharmacogenetic tests, personalized medical tests, gene sequencing-based tests and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; providing pharmaceutical information services in all media; scientific research services; design for others in the field of DNA-based assays, DNA sequencing protocols, immunoassay and methods for drug discovery; scientific research, namely, development of pharmaceuticals and development of diagnostic methods in the field of clinical laboratory testing; agrochemical product development for others

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 31, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 31, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events


Event DateEvent Description
Friday, December 31, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, June 28, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, December 12, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, December 12, 2016REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, November 17, 2016TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, August 12, 2016POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Thursday, August 11, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 28, 2016TEAS SECTION 8 & 15 RECEIVED
Tuesday, June 28, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 28, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, April 12, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2011PUBLISHED FOR OPPOSITION
Tuesday, March 8, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 7, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 7, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 7, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 24, 2011ASSIGNED TO LIE
Wednesday, February 23, 2011TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, February 22, 2011NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, February 22, 2011FINAL REFUSAL E-MAILED
Tuesday, February 22, 2011FINAL REFUSAL WRITTEN
Friday, January 28, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 28, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 19, 2011ASSIGNED TO LIE
Friday, January 14, 2011ASSIGNED TO LIE
Friday, December 31, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 29, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 29, 2010NON-FINAL ACTION E-MAILED
Wednesday, December 29, 2010NON-FINAL ACTION WRITTEN
Thursday, December 23, 2010ASSIGNED TO EXAMINER
Tuesday, October 12, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 11, 2010NEW APPLICATION ENTERED IN TRAM